PUBLIC COMPANY
saveITB-Med AB
updated 2mo ago
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase1A Study of TCD601 (Siplizumab) in Newly Diagnosed Adult Amyotrophic Lateral Sclerosis (ALS) Patients
- phase2A Dose Escalation Study of TCD601 Compared to ATG in de Novo Renal Transplantation
- phase2A Study of TCD601 in the Induction of Tolerance in Renal Transplantation (PERSPECTIVE)
- phase2A Study of TCD601 in the Induction of Tolerance in Renal Transplantation (PANORAMA)
- phase2A Study of TCD601 in de Novo Renal Transplant Recipients
- phase2A Study of TCD601 (Siplizumab) in New Onset Type 1 Diabetes Patients
- phase2A Dose Escalation Study in de Novo Renal Transplantation
- phase2A Study of TCD601 in the Induction of Tolerance in de Novo Liver Transplantation
🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that